Moreover, we analyzed the publicly available RNA-Seq neuroblastoma data set consisting of 498 human neuroblastoma samples, and Kaplan-Meier analysis showed that patients who had higher ADAMTS9-AS2 levels had longer overall survival (P = 0.036; Supplemental Figure 1E). The gene discussed is ADAMTS9; the disease is neuroblastoma.